Libring et al. [135] recently demonstrated a dynamic relationship between the tumour and stromal cells within the tumour microenvironment in which the levels and fibrillization of fibronectin in the ECM are modulated during the particular stages of metastatic progression. This evidence concerns the gene FN1 and neoplasm.